Genpact Ltd has a consensus price target of $42.18, established from looking at the 35 latest analyst ratings. The last 3 analyst ratings were released from Citigroup, JP Morgan, and Needham on April 22, 2024, February 9, 2024, and February 9, 2024. With an average price target of $38.67 between Citigroup, JP Morgan, and Needham, there's an implied 22.11% upside for Genpact Ltd from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
04/22/2024 | G | Buy Now | Genpact | $31.66 | 4.22% | Citigroup | Ashwin Shirvaikar | $36 → $33 | Maintains | Neutral | Get Alert |
02/09/2024 | G | Buy Now | Genpact | $31.66 | 35.8% | JP Morgan | Tien-Tsin Huang | $42 → $43 | Maintains | Underweight | Get Alert |
02/09/2024 | G | Buy Now | Genpact | $31.66 | 26.32% | Needham | Mayank Tandon | → $40 | Reiterates | Buy → Buy | Get Alert |
01/30/2024 | G | Buy Now | Genpact | $31.66 | 26.32% | Mizuho | Dan Dolev | → $40 | Initiates | → Neutral | Get Alert |
01/17/2024 | G | Buy Now | Genpact | $31.66 | 13.69% | Citigroup | Ashwin Shirvaikar | $35 → $36 | Maintains | Neutral | Get Alert |
12/15/2023 | G | Buy Now | Genpact | $31.66 | 20.01% | Baird | David Koning | → $38 | Downgrade | Outperform → Neutral | Get Alert |
11/09/2023 | G | Buy Now | Genpact | $31.66 | 26.32% | Needham | Mayank Tandon | $50 → $40 | Maintains | Buy | Get Alert |
08/22/2023 | G | Buy Now | Genpact | $31.66 | 26.32% | JP Morgan | Tien-Tsin Huang | → $40 | Downgrade | Neutral → Underweight | Get Alert |
08/11/2023 | G | Buy Now | Genpact | $31.66 | 57.9% | Needham | Mayank Tandon | $56 → $50 | Maintains | Buy | Get Alert |
08/10/2023 | G | Buy Now | Genpact | $31.66 | 26.32% | JP Morgan | Tien-Tsin Huang | $46 → $40 | Maintains | Neutral | Get Alert |
08/10/2023 | G | Buy Now | Genpact | $31.66 | 42.11% | Wedbush | Moshe Katri | → $45 | Reiterates | Neutral → Neutral | Get Alert |
08/10/2023 | G | Buy Now | Genpact | $31.66 | 29.48% | BMO Capital | Keith Bachman | $46 → $41 | Maintains | Market Perform | Get Alert |
07/18/2023 | G | Buy Now | Genpact | $31.66 | 32.64% | Citigroup | Ashwin Shirvaikar | $46 → $42 | Downgrade | Buy → Neutral | Get Alert |
06/07/2023 | G | Buy Now | Genpact | $31.66 | 42.11% | Wedbush | Moshe Katri | → $45 | Reiterates | Neutral → Neutral | Get Alert |
05/15/2023 | G | Buy Now | Genpact | $31.66 | 29.48% | Jefferies | Surinder Thind | $47 → $41 | Maintains | Hold | Get Alert |
05/11/2023 | G | Buy Now | Genpact | $31.66 | 45.27% | BMO Capital | Keith Bachman | $53 → $46 | Maintains | Market Perform | Get Alert |
05/11/2023 | G | Buy Now | Genpact | $31.66 | 38.95% | TD Cowen | Bryan Bergin | $48 → $44 | Maintains | Market Perform | Get Alert |
05/11/2023 | G | Buy Now | Genpact | $31.66 | 51.59% | Baird | David Koning | $54 → $48 | Maintains | Outperform | Get Alert |
05/11/2023 | G | Buy Now | Genpact | $31.66 | 76.85% | Needham | Mayank Tandon | → $56 | Reiterates | Buy → Buy | Get Alert |
The latest price target for Genpact (NYSE: G) was reported by Citigroup on April 22, 2024. The analyst firm set a price target for $33.00 expecting G to rise to within 12 months (a possible 4.22% upside). 20 analyst firms have reported ratings in the last year.
The latest analyst rating for Genpact (NYSE: G) was provided by Citigroup, and Genpact maintained their neutral rating.
There is no last upgrade for Genpact.
The last downgrade for Genpact Ltd happened on December 15, 2023 when Baird changed their price target from N/A to $38 for Genpact Ltd.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Genpact, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Genpact was filed on April 22, 2024 so you should expect the next rating to be made available sometime around April 22, 2025.
While ratings are subjective and will change, the latest Genpact (G) rating was a maintained with a price target of $36.00 to $33.00. The current price Genpact (G) is trading at is $31.67, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.